The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially preterm babies and infants under six months old. The younger the child, the ...

With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.

Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

But which ones should you get? This year marks the second season for the new respiratory syncytial virus vaccine (RSV) for grown-ups. While not everyone needs it, the evidence so far suggests that ...

Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...

Almost all children will get RSV during their first two years, but each year up to 80,000 children are hospitalized due to it. Now, a new FDA approved vaccine can protect your baby—even before the ...

Notably, quarterly sales of the company’s RSV vaccine, which became a blockbuster after debuting last year, fell by more than 70% year over year, in part due to narrower U.S. recommendations for ...